Population pharmacokinetics and pharmacodynamics of IONIS-GCGRRx, an antisense oligonucleotide for type 2 diabetes mellitus: a red blood cell lifespan model Kenneth T. LuuErin S. MorganYanfeng Wang Original Paper 28 January 2017 Pages: 179 - 191
Empirical models for fitting of oral concentration time curves with and without an intravenous reference Michael Weiss Original Paper 01 February 2017 Pages: 193 - 201
Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments Robert AnderssonTobias KroonJohan Gabrielsson Original Paper Open access 21 February 2017 Pages: 203 - 222
Nonlinear mixed-effects models for pharmacokinetic data analysis: assessment of the random-effects distribution Reza Drikvandi Original Paper 13 February 2017 Pages: 223 - 232
Comparison of non-compartmental and mixed effect modelling methods for establishing bioequivalence for the case of two compartment kinetics and censored concentrations Jim H. HughesRichard N. UptonDavid J. R. Foster Original Paper 13 February 2017 Pages: 233 - 244
Exposure–response analyses of blood pressure and heart rate changes for methylphenidate in healthy adults Liang LiYaning WangHao Zhu Original Paper 18 February 2017 Pages: 245 - 262
Exposure–disease response analysis of natalizumab in subjects with multiple sclerosis Kumar Kandadi MuralidharanDeb SteinerIvan Nestorov Original Paper 01 March 2017 Pages: 263 - 275
Population PBPK modelling of trastuzumab: a framework for quantifying and predicting inter-individual variability Paul R. V. MalikAbdullah HamadehAndrea N. Edginton Original Paper 04 March 2017 Pages: 277 - 290